Thomas Giese1, Martin Zeier, Stefan Meuer. 1. Department of Immunology, University of Heidelberg, Im Neuenheimer Feld 305, 69120 Heidelberg,Germany. thomas.giese@urz.uni-heidelberg.de
Abstract
BACKGROUND: With the introduction of cyclosporine A (CsA) long-term allograft function has been significantly improved. Problems regarding limited therapeutic margins and CsA toxicity remain unsolved. Up to now there are no reliable, practical markers to measure the biological activity of CsA in vivo. METHODS: Expression of nuclear factor of activated T lymphocytes (NFAT)-regulated genes in PMA/ionomycin-stimulated peripheral blood from stable renal-transplant (n = 25) recipients under CsA therapy were measured by quantitative real-time RT-PCR before and 2 h after drug intake. The relative expression of three NFAT-regulated genes was scored, averaged and presented as the multi-gene expression score ranging from 0 to 12 points. Gene expression data and CsA plasma levels were correlated. RESULTS: A reliable and precise method to measure functional consequences of calcineurin inhibition in the individual patient was established. The individual decline in NFAT-regulated gene expression and the total drug exposure were in close relation (rho = 0.602). CONCLUSION: Quantitative measurement of NFAT-regulated gene expression in CsA-treated patients represents a potent new approach to assess the biological effectiveness of CsA therapy and has the potential to enable individualized immunosuppressive regimens.
BACKGROUND: With the introduction of cyclosporine A (CsA) long-term allograft function has been significantly improved. Problems regarding limited therapeutic margins and CsAtoxicity remain unsolved. Up to now there are no reliable, practical markers to measure the biological activity of CsA in vivo. METHODS: Expression of nuclear factor of activated T lymphocytes (NFAT)-regulated genes in PMA/ionomycin-stimulated peripheral blood from stable renal-transplant (n = 25) recipients under CsA therapy were measured by quantitative real-time RT-PCR before and 2 h after drug intake. The relative expression of three NFAT-regulated genes was scored, averaged and presented as the multi-gene expression score ranging from 0 to 12 points. Gene expression data and CsA plasma levels were correlated. RESULTS: A reliable and precise method to measure functional consequences of calcineurin inhibition in the individual patient was established. The individual decline in NFAT-regulated gene expression and the total drug exposure were in close relation (rho = 0.602). CONCLUSION: Quantitative measurement of NFAT-regulated gene expression in CsA-treated patients represents a potent new approach to assess the biological effectiveness of CsA therapy and has the potential to enable individualized immunosuppressive regimens.
Authors: Sara Bremer; Nils T Vethe; Morten Skauby; Margrete Kasbo; Elisabet D Johansson; Karsten Midtvedt; Stein Bergan Journal: Br J Clin Pharmacol Date: 2017-08-16 Impact factor: 4.335
Authors: J L Haraschak; V C Langston; R Wang; C Riggs; C Fellman; M K Ross; C Bulla; K Lunsford; A Mackin; T Archer Journal: J Vet Pharmacol Ther Date: 2013-11-13 Impact factor: 1.786
Authors: Christopher Vollmers; Iwijn De Vlaminck; Hannah A Valantine; Lolita Penland; Helen Luikart; Calvin Strehl; Garrett Cohen; Kiran K Khush; Stephen R Quake Journal: PLoS Med Date: 2015-10-14 Impact factor: 11.069
Authors: Nynke M Kannegieter; Dennis A Hesselink; Marjolein Dieterich; Gretchen N de Graav; Rens Kraaijeveld; Carla C Baan Journal: Sci Rep Date: 2017-11-09 Impact factor: 4.379
Authors: Nynke M Kannegieter; Dennis A Hesselink; Marjolein Dieterich; Gretchen N de Graav; Rens Kraaijeveld; Carla C Baan Journal: PLoS One Date: 2018-07-23 Impact factor: 3.240